222 related articles for article (PubMed ID: 24935433)
21. Complement C5a receptors C5L2 and C5aR in renal fibrosis.
Martin IV; Bohner A; Boor P; Shagdarsuren E; Raffetseder U; Lammert F; Floege J; Ostendorf T; Weber SN
Am J Physiol Renal Physiol; 2018 Jan; 314(1):F35-F46. PubMed ID: 28903945
[TBL] [Abstract][Full Text] [Related]
22. C3a and C5a promote renal ischemia-reperfusion injury.
Peng Q; Li K; Smyth LA; Xing G; Wang N; Meader L; Lu B; Sacks SH; Zhou W
J Am Soc Nephrol; 2012 Sep; 23(9):1474-85. PubMed ID: 22797180
[TBL] [Abstract][Full Text] [Related]
23. C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage.
Yuan B; Fu F; Huang S; Lin C; Yang G; Ma K; Shi H; Yang Z
Mol Neurobiol; 2017 Oct; 54(8):6187-6197. PubMed ID: 27709492
[TBL] [Abstract][Full Text] [Related]
24. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils.
de Vries B; Köhl J; Leclercq WK; Wolfs TG; van Bijnen AA; Heeringa P; Buurman WA
J Immunol; 2003 Apr; 170(7):3883-9. PubMed ID: 12646657
[TBL] [Abstract][Full Text] [Related]
25. Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury.
Frantz S; Tillmanns J; Kuhlencordt PJ; Schmidt I; Adamek A; Dienesch C; Thum T; Gerondakis S; Ertl G; Bauersachs J
Am J Pathol; 2007 Aug; 171(2):507-12. PubMed ID: 17556593
[TBL] [Abstract][Full Text] [Related]
26. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
[TBL] [Abstract][Full Text] [Related]
27. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
28. Complement C5a-C5aR interaction enhances MAPK signaling pathway activities to mediate renal injury in trichloroethylene sensitized BALB/c mice.
Zhang JX; Zha WS; Ye LP; Wang F; Wang H; Shen T; Wu CH; Zhu QX
J Appl Toxicol; 2016 Feb; 36(2):271-84. PubMed ID: 26095957
[TBL] [Abstract][Full Text] [Related]
29. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit.
Williams MW; Taft CS; Ramnauth S; Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 1995 Jul; 30(1):79-86. PubMed ID: 7553727
[TBL] [Abstract][Full Text] [Related]
30. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.
Wenderfer SE; Ke B; Hollmann TJ; Wetsel RA; Lan HY; Braun MC
J Am Soc Nephrol; 2005 Dec; 16(12):3572-82. PubMed ID: 16207826
[TBL] [Abstract][Full Text] [Related]
31. Complement 5a receptor mediates angiotensin II-induced cardiac inflammation and remodeling.
Zhang C; Li Y; Wang C; Wu Y; Cui W; Miwa T; Sato S; Li H; Song WC; Du J
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1240-8. PubMed ID: 24743429
[TBL] [Abstract][Full Text] [Related]
32. Expression of C5a and its receptor following spinal cord ischemia reperfusion injury in the rat.
Dong Q; Sun L; Peng L; Yan B; Lv J; Wang G; Gong S
Spinal Cord; 2015 Aug; 53(8):581-4. PubMed ID: 25917954
[TBL] [Abstract][Full Text] [Related]
33. The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury.
Cao Z; Hu Y; Wu W; Ha T; Kelley J; Deng C; Chen Q; Li C; Li J; Li Y
Cardiovasc Res; 2009 Dec; 84(3):442-51. PubMed ID: 19586942
[TBL] [Abstract][Full Text] [Related]
34. C5aR activation in the absence of C5a: A new disease mechanism of autoimmune hemolytic anemia in mice.
Syed SN; Rau E; Ziegelmann M; Sogkas G; Brüne B; Schmidt RE
Eur J Immunol; 2018 Apr; 48(4):696-704. PubMed ID: 29277896
[TBL] [Abstract][Full Text] [Related]
35. Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury.
Ke D; Fang J; Fan L; Chen Z; Chen L
Coron Artery Dis; 2013 Jun; 24(4):334-41. PubMed ID: 23531479
[TBL] [Abstract][Full Text] [Related]
36. C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.
Hornum L; Hansen AJ; Tornehave D; Fjording MS; Colmenero P; Wätjen IF; Søe Nielsen NH; Bliddal H; Bartels EM
PLoS One; 2017; 12(12):e0189017. PubMed ID: 29220376
[TBL] [Abstract][Full Text] [Related]
37. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
38. Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats.
Arumugam TV; Woodruff TM; Stocks SZ; Proctor LM; Pollitt S; Shiels IA; Reid RC; Fairlie DP; Taylor SM
J Hepatol; 2004 Jun; 40(6):934-41. PubMed ID: 15158333
[TBL] [Abstract][Full Text] [Related]
39. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
Atkinson SM; Nansen A; Usher PA; Sondergaard BC; Mackay CR; Friedrichsen B; Chang CC; Tang R; Skov S; Haase C; Hornum L
Autoimmunity; 2015; 48(7):460-70. PubMed ID: 25915570
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization.
Riley RD; Sato H; Zhao ZQ; Thourani VH; Jordan JE; Fernandez AX; Ma XL; Hite DR; Rigel DF; Pellas TC; Peppard J; Bill KA; Lappe RW; Vinten-Johansen J
J Thorac Cardiovasc Surg; 2000 Aug; 120(2):350-8. PubMed ID: 10917953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
